Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 120486
Published online Aug 15, 2026. doi: 10.4251/wjgo.120486
Published online Aug 15, 2026. doi: 10.4251/wjgo.120486
Table 1 Comparison of general information between the two groups of patients, n (%)/mean ± SD
| Index | Observation group (n = 50) | Control group (n = 50) | χ2/t | P value |
| Gender | 0.16 | 0.689 | ||
| Male | 28 (56.00) | 26 (52.00) | ||
| Female | 22 (44.00) | 24 (48.00) | ||
| Age (years) | 12.35 ± 4.18 | 20.46 ± 4.52 | 2.23 | 0.028 |
| Disease duration (months) | 6.15 ± 2.38 | 12.58 ± 3.15 | 0.98 | 0.328 |
| Sites of tumor metastasis | 42.85 ± 5.63 | 33.67 ± 5.24 | 0.35 | 0.951 |
| Liver | 23 (46.00) | 21 (42.00) | ||
| Lung | 15 (30.00) | 16 (32.00) | ||
| Abdominal cavity | 8 (16.00) | 9 (18.00) | ||
| Other | 4 (8.00) | 4 (8.00) | ||
| Baseline NRS score (scores) | 26.34 ± 4.15 | 18.75 ± 3.86 | 0.38 | 0.705 |
- Citation: Wang XY, Wang ZD, Kan K, Guo XX. Impact of combined pregabalin and multimodal analgesia on cancer pain and quality of life in advanced colorectal cancer. World J Gastrointest Oncol 2026; 18(8): 120486
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/120486.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120486